Consequences of incomplete antibacterial treatment for chlamydial pelvic inflammatory disease.
Health Decisions, Inc., Chapel Hill, North Carolina, USA.
M J
MJ
Rosenberg
M S
MS
Waugh
D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000188:drug therapy / Q000191:economics* / Q000382:microbiology; D017281:Cost of Illness; D004318:Doxycycline / Q000191:economics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000191:economics* / Q000382:microbiology; D016312:Treatment Refusal
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004318:Doxycycline